The class III PI3K Vacuolar protein sorting 34 (Vps34) plays a role in both canonical and noncanonical autophagy, key processes that control the presentation of antigens by dendritic cells (DCs) to naive T lymphocytes. We generated DC-specific Vps34-deficient mice to assess the contribution of Vps34 to DC functions. We found that DCs from these animals have a partially activated phenotype, spontaneously produce cytokines, and exhibit enhanced activity of the classic MHC class I and class II antigen-presentation pathways. Surprisingly, these animals displayed a defect in the homeostatic maintenance of splenic CD8α + DCs and in the capacity of these cells to cross-present cell corpse-associated antigens to MHC class I-restricted T cells, a property that was associated with defective expression of the T-cell Ig mucin (TIM)-4 receptor. Importantly, mice deficient in the Vps34-associated protein Rubicon, which is critical for a noncanonical form of autophagy called "Lightchain 3 (LC3)-associated phagocytosis" (LAP), lacked such defects. Finally, consistent with their defect in the cross-presentation of apoptotic cells, DC-specific Vps34-deficient animals developed increased metastases in response to challenge with B16 melanoma cells. Collectively, our studies have revealed a critical role of Vps34 in the regulation of CD8α + and CD4 + T cells, respectively. MHC class II-associated peptides are typically generated by proteolysis of endocytosed proteins (1), whereas MHC class I-associated peptides are predominantly generated by proteolysis of cytosolic proteins (2). However, in specialized antigen-presenting cells (APCs) such as a DC subset expressing CD8α and CD103, extracellular antigens can be presented in the context of MHC class I molecules via a cross-presentation pathway whose mechanism is incompletely understood (3).
The class III PI3K Vacuolar protein sorting 34 (Vps34) plays a role in both canonical and noncanonical autophagy, key processes that control the presentation of antigens by dendritic cells (DCs) to naive T lymphocytes. We generated DC-specific Vps34-deficient mice to assess the contribution of Vps34 to DC functions. We found that DCs from these animals have a partially activated phenotype, spontaneously produce cytokines, and exhibit enhanced activity of the classic MHC class I and class II antigen-presentation pathways. Surprisingly, these animals displayed a defect in the homeostatic maintenance of splenic CD8α
+ DCs and in the capacity of these cells to cross-present cell corpse-associated antigens to MHC class I-restricted T cells, a property that was associated with defective expression of the T-cell Ig mucin (TIM)-4 receptor. Importantly, mice deficient in the Vps34-associated protein Rubicon, which is critical for a noncanonical form of autophagy called "Lightchain 3 (LC3)-associated phagocytosis" (LAP), lacked such defects. Finally, consistent with their defect in the cross-presentation of apoptotic cells, DC-specific Vps34-deficient animals developed increased metastases in response to challenge with B16 melanoma cells. Collectively, our studies have revealed a critical role of Vps34 in the regulation of CD8α + DC homeostasis and in the capacity of these cells to process and present antigens associated with apoptotic cells to MHC class I-restricted T cells. Our findings also have important implications for the development of small-molecule inhibitors of Vps34 for therapeutic purposes. + and CD4 + T cells, respectively. MHC class II-associated peptides are typically generated by proteolysis of endocytosed proteins (1), whereas MHC class I-associated peptides are predominantly generated by proteolysis of cytosolic proteins (2) . However, in specialized antigen-presenting cells (APCs) such as a DC subset expressing CD8α and CD103, extracellular antigens can be presented in the context of MHC class I molecules via a cross-presentation pathway whose mechanism is incompletely understood (3) .
In recent years, the process of autophagy has been implicated in controlling antigen processing (4) . Autophagy is a conserved catabolic process that maintains cellular energy homeostasis in response to a wide spectrum of cellular stresses (5, 6) . Autophagy ensures continuous degradation of long-lived proteins, damaged cellular organelles, and protein aggregates to facilitate recycling of nutrients and hence promote cellular metabolism. The formation of autophagosomes requires an interplay between autophagyrelated (Atg) gene products, which have been well characterized in yeast and are conserved in mammals (7) . Defective autophagy in mammalian cells results in the accumulation of damaged cellular organelles and protein aggregates, leading to stress with pathological consequences (8) . Autophagy has common features with endocytosis, with which it shares effector molecules (9) . However, how these processes and their shared machinery regulate antigen presentation remains incompletely understood.
Vacuolar protein sorting 34 (Vps34) is a class III PI3K that plays a role in endocytosis, intracellular vesicular trafficking, and autophagosome formation during autophagy (10) . Vps34-deficient cells display defective autophagic flux leading to the accumulation of aggregated cellular proteins and organelles, and Vps34 ablation in mice causes significant pathology (11) (12) (13) (14) . Although Vps34 forms multiple protein complexes that mediate its diverse cellular functions in canonical autophagy, noncanonical autophagy, and endocytosis (15) , it is unclear which of these processes is responsible for the phenotypes observed in Vps34-deficient cells and mice.
In the present study, we generated mice with a DC-specific deletion of Vps34 to determine its effects on DC functions such as antigen presentation and priming of adaptive immune responses. Our findings revealed a critical role for Vps34 in the homeostasis and function of DCs that is dependent on the canonical autophagy pathway.
Results

DC-Specific Vps34-Deficient Mice Exhibit a Selective Reduction in CD8α
+ DCs. We generated Vps34 f/f ;CD11c-Cre mice, which exhibited selective Vps34 ablation in DCs (Fig. S1 ). Although these mice displayed no signs of disease and were grossly indistinguishable Significance Dendritic cells (DCs) of the immune system are critical for displaying foreign antigens to T lymphocytes, a process called "antigen presentation." This process may involve Vacuolar protein sorting 34 (Vps34), a protein implicated in diverse cellular processes, including endocytosis, an extracellular product uptake system, and autophagy, an intracellular degradation system. Here we have generated and analyzed mice in which the Vps34 gene is specifically knocked out in DCs. These animals displayed defects in the survival and function of a subset of DCs specialized in presenting antigens from dead cells to T cells. Thus our findings have revealed a critical contribution of Vps34 in DC functions that may have important implications for targeting this pathway for therapeutic purposes.
from control littermates, their lymphoid organs were visibly enlarged compared with control animals (Fig. 1A) , and lymphoid cellularity was increased (Fig. 1B) .
Conventional DCs in lymphoid organs are a heterogeneous population of CD11b int
CD11c
hi cells that can be further subdivided into populations expressing CD8α and CD103 (16) . Although we found no differences in the frequency of total DCs (Fig.  1C) , the absolute numbers of DCs were significantly increased in the lymphoid organs of Vps34 f/f ;CD11c-Cre mice (Fig. 1C) . The prevalence of the DC population expressing CD103 and CD8α in Vps34 f/f ;CD11c-Cre mice was sharply reduced (Fig. 1 D and E) , although absolute numbers were comparable in both groups of mice (Fig. 1E ). CD11b
−
CD103
+ cells are a major population of DCs in the lungs (17) that are developmentally related to conventional CD8α
+ DCs in the spleen (16) . We observed a trend for reduced frequency of such DCs in the lungs of Vps34 f/f ;CD11c-Cre mice (Fig. 1 F and G) . S3) . Thus, these data suggest that the increased numbers of DCs in the lymphoid organs of Vps34 f/f ;CD11c-Cre mice are associated with concomitant increases in T, B, and NK cells, thereby increasing the overall cellularity and size of the lymphoid organs.
To determine if the selective reduction of CD8α + DCs in the spleen is related to defects in their development or homeostasis, we analyzed young mice that contained comparable numbers of cells, suggesting normal DC development (Fig. 1H) . To determine if the loss of CD8α + DCs in older mice was cell intrinsic, we generated mixed bone marrow chimeras using wild-type and Vps34 + DCs in the spleen (18) . We found that this population of DCs from Vps34 f/f ;CD11c-Cre mice was present at normal levels early (day 9) after culture but was reduced at a later time point (day 21) compared with the control cultures (Fig. 1J ). Despite differences in the timing of DC development in vitro vs. in vivo, these findings are consistent with defects in DC homeostasis rather than development.
Spontaneous DC Activation in Vps34
f/f ;CD11c-Cre Mice. We next assessed the DC activation status during steady-state conditions and found that Vps34-deficient DCs expressed modestly increased levels of CD40 and MHC class I and class II molecules but not CD80 or CD86, suggesting a partially activated state ( Fig. 2A) . Additionally, we found that Vps34-deficient DCs spontaneously secrete copious amounts of both pro-and anti-inflammatory cytokines such as TNFα, IL-6, and IL-10 ( Fig. 2B) , as is consistent with a prior study performed in vitro with a small-molecule inhibitor of Vps34, SAR405 (19) . Upon activation with Toll-like receptor (TLR) ligands, no substantial enhancement of cytokine secretion by Vps34-deficient DCs was observed compared with control DCs. We obtained similar results for activated BMDCs, but these cells did not spontaneously produce cytokines (Fig. 2 C  and D) , perhaps because of the lack of continuous exposure to TLR ligands, as may be the case for splenic DCs in vivo. Collectively, these results indicate that DCs from Vps34 f/f ;CD11c-Cre mice exhibit a partially activated phenotype with spontaneous production of both pro-and anti-inflammatory cytokines. Enhancement of the Classic MHC Class I and Class II AntigenPresentation Pathways. Because autophagy has been implicated in antigen presentation (4), we analyzed this function of Vps34-deficient DCs. These cells were as effective as wild-type DCs in presenting an ovalbumin (OVA)-derived peptide to H-2K b -restricted OT-I T cells ( Fig. 3 A and B) . However, Vps34-deficient DCs exhibited enhanced capacity to present cytoplasmic OVA antigens to OT-I cells (Fig. 3B ). We repeated this experiment with sorted CD8α
+ and CD8α − DC populations and found that both subsets of Vps34-deficient DCs exhibited enhanced antigen presentation ( Fig. 3 C and D) . We obtained comparable results with BMDCs (Fig. 3E) . Similarly, Vps34-deficient DCs showed enhanced capacity to present immunodominant lymphocytic choriomeningitis virus (LCMV) epitopes to cytotoxic T lymphocyte (CTL) lines (Fig.  3F ). To test whether the partially activated phenotype of Vps34-deficient DCs plays a role, we activated purified splenic DCs with reagents that up-regulate MHC class I expression. We found that IFN-γ enhanced up-regulation of MHC class I (but not MHC class II) expression (Fig. S4 ) on Vps34-deficient DCs compared with control cells (Fig. 3 G and H), suggesting that the partially activated phenotype of Vps34-deficient DCs renders them even more sensitive to IFN-γ-mediated up-regulation of MHC class I and its associated antigen-processing machinery.
Next, we evaluated the MHC class II antigen-processing pathway. We found that Vps34-deficient and wild-type DCs had similar capacity to present an OVA-derived peptide to OT-II T cells (Fig. 4A) , but Vps34-deficient DCs showed an enhanced capacity to present soluble OVA protein (Fig. 4B) . This finding was true for both the CD8α + and CD8α − DC subsets (Fig. 4 C  and D) . Similar results were obtained for BMDCs (Fig. 4 E and  F) . To determine whether the observed differences in MHC class II-restricted antigen presentation were to the result of the role of Vps34 in endocytosis, we tested the capacity of Vps34-deficient and wild-type BMDCs to endocytose particulate matter (fluorescent microbeads), soluble proteins (chimeric Eα-GFP protein), and bacteria (Citrobacter rodentium) in the presence or absence of the phagocytosis inhibitor cytochalasin D. We found that Vps34-deficient DCs exhibited modestly reduced uptake (Fig. S5) , suggesting that these cells do not possess a major inherent defect in endocytosis or phagocytosis.
Defective Cell Corpse-Associated Antigen Cross-Presentation. In addition to presenting endogenous antigens on MHC class I molecules, CD8α
+ DCs can present exogenous antigens to MHC class I-restricted T cells in a process called "cross-presentation" (20) . We sorted CD8α
+ and CD8α − DCs to measure their capacity to cross-present the model antigen OVA delivered in four different forms: soluble, targeted to DCs with anti-DEC205 antibodies, expressed by Listeria monocytogenes bacteria, and contained by apoptotic cells. We found that Vps34-deficient CD8α + DCs were equally as efficient as wild-type DCs in cross-presenting free OVA (Fig. 5A) , OVA delivered to DCs via DEC205 (Fig. 5B) , and OVA produced by L. monocytogenes (Fig. 5C) . In sharp contrast, Vps34-deficient DCs displayed a marked defect in cross-presenting OVA antigens associated with apoptotic cells (Fig. 5D) . Next, we measured cross-presentation of OVA-associated cell corpses in vivo after mice were injected with OVA-loaded, sublethally irradiated TAP −/− splenocytes and demonstrated a profound defect in Vps34 f/f ;CD11c-Cre mice (Fig. 5E) . Collectively, these results showed that Vps34-deficient DCs possess a competent crosspresentation pathway, but their capacity to cross-present cell corpse-associated antigens is impaired.
Defective Uptake of Cell Corpses Correlates with Reduced T-Cell Ig
Mucin-4 Expression. We next explored the mechanism of defective cross-presentation of apoptotic cells by Vps34-deficient DCs. First, we determined the capacity of DCs to take up apoptotic cells in vivo and in vitro. For in vivo experiments, we injected sublethally irradiated splenocytes into groups of Vps34 f/f ;CD11c-Cre and Vps34 f/f mice and found that Vps34-deficient CD8α + DCs were defective in taking up apoptotic cells (Fig. 6 A and B) .
A similar apoptotic cell uptake experiment was carried out in vitro and showed that Vps34-deficient CD8α + DCs were less efficient than control DCs in phagocytosing apoptotic cells ( Fig.  6 C and D) . Thus, we concluded that Vps34-deficient CD8α + DCs are selectively defective in efferocytosis. (21) . Thus, we investigated mRNA expression of several of these receptors and found profoundly reduced expression of the T-cell Ig mucin (TIM)-4 receptor, but not of any other receptors investigated, on Vps34-deficient DCs (Fig. 6E) . TIM-4, a receptor for phosphatidylserine, plays a critical role in the cross-presentation of apoptotic cells by phagocytes (22) . We next tested surface expression of TIM-4 and found that CD8α + DCs expressed higher levels of TIM-4 receptor on the cell surface than did CD8α
− DCs from either group of mice. Interestingly, TIM-4 expression was consistently reduced on Vps34-mutant CD8α + DCs compared with control DCs (Fig. 6 F and G) . To rule out potential artifacts mediated by Cre expression, we analyzed Vps34 +/+ ;CD11c-Cre mice, which had a phenotype similar to the wild-type and Vps34 f/f control animals used throughout these studies (Fig. S6) , indicating that the observed defects were mediated by Vps34 ablation.
We
+ DCs were reduced in prevalence compared with wild-type CD8α + DCs (Fig. 1I) . Further, Vps34-deficient CD8α
+ DCs exhibited reduced TIM-4 expression and a reduced capacity to take up dead cells compared with wild-type CD8α + DCs (Fig. S7) , indicating that the cytokines produced constitutively by Vps34-deficient CD8α + DCs fail to impair TIM-4 expression or the uptake of apoptotic cells by wild-type CD8α + DCs in vivo. This conclusion was supported by cocultures of DCs derived from Vps34 f/f ;CD11c-Cre and Vps34 f/f mice (1:1 ratio) for 24 h, which did not affect TIM-4 expression on either mutant or wild-type DCs (Fig. S8A) . In a similar experiment, coculture of DCs from Vps34 f/f ;CD11c-Cre mice and whole splenocytes derived from Vps34 f/f mice failed to influence TIM-4 expression on Vps34 mutant DCs (Fig. S8 B and C) . We also considered that IL-10, one of the immunosuppressive cytokines spontaneously produced by Vps34-deficient DCs (Fig. 2) , may potentially impact TIM-4 expression, but we found that IL-10 treatment had no effect on TIM-4 expression by wild-type DCs (Fig. S8D) .
In an attempt to provide direct evidence for reduced TIM-4 expression as a cause of defective efferocytosis by Vps34-deficient DCs, we transfected these cells with a TIM-4-containing expression vector, but, as was consistent with similar attempts to transfect primary DCs by other investigators (23), we were unsuccessful. As an alternative approach, we used the DC2.4 cell line (24) and primary BMDCs, which lack TIM-4 expression (Fig. 6 H and I) . Transfection with the TIM-4 expression vector resulted in efficient TIM-4 surface expression, which in turn enhanced the uptake of apoptotic cells (Fig. 6 H and I) , demonstrating that TIM-4 can function as a phagocytic receptor for apoptotic cells on DCs. Although these findings point to blunted TIM-4 expression as a likely defect in Vps34-deficient DCs evoking defective efferocytosis, they do not exclude the possibility that other phagocytic receptors are involved.
DC Defects Are Independent of Light Chain 3-Associated Phagocytosis.
The Beclin1-Vps34 complex is used by the canonical autophagy process as well as by light chain 3 (LC3)-associated phagocytosis (LAP) (25) . The protein Rubicon is critically required for LAP but not for canonical autophagy (26) . Therefore, we analyzed DCs from Rubicon-deficient mice, which exhibited normal prevalence of the CD8α + subset (Fig. 7 A and B) , lack of constitutive cytokine production (Fig. 7C) , normal TIM-4 surface expression (Fig. 7D) , and a normal capacity to take up dead cells (Fig. 7E) . These results indicate that the alterations in CD8α
+ DCs observed in Vps34-mutant mice are most likely not caused by defective noncanonical autophagy. Instead, electron microscopy studies revealed autophagosomal double-membrane structures, indicating defective canonical autophagy, in wild-type but not Vps34-deficient DCs (Fig. S9A) . To provide further support for defects in canonical autophagy in Vps34-deficient DCs, we measured mitochondrial and endoplasmic reticulum (ER) mass, which was enhanced in Vps34-deficient compared with wild-type DCs (Fig.  S9B ). Although these findings are consistent with the premise that the observed phenotypes in Vps34-deficient DCs are mediated by defects in canonical autophagy, we cannot exclude a role for other cellular processes in which Vps34 is involved.
Defective Induction of Responses to Apoptotic Cell-Associated
Antigens. To investigate the functional consequences of Vps34 ablation in DCs on the induction of an immune response, we measured CTL responses to cell corpse-associated antigens in vivo. Sublethally irradiated, OVA-loaded TAP −/− splenocytes were injected into mice, and 7 d later we measured OVA 257-264 -specific CTL responses. Consistent with the relative reduction of CD8α + DCs in spleens of Vps34 f/f ;CD11c-Cre mice and defects in the cross-presentation of apoptotic cells (Fig. 5E) , the results showed efficient induction of OVA-specific CTLs in Vps34 f/f mice but a blunted response in Vps34 f/f ;CD11c-Cre mice (Fig. 8) .
Enhanced B16 Lung Melanoma Metastases. Recent studies on CD8α + DCs have shown that these DCs have a critical role in crosspresenting tumor-associated antigens and in inducing tumor-specific CTLs (27) . We therefore challenged Vps34 ;CD11c-Cre mice possessed significantly higher tumor burdens than Vps34 f/f control mice (Fig. 9) . CD11b
−
CD11c
hi DCs in the lungs are developmentally related to splenic CD11c
+ DCs (16) . This population of DCs in the lungs was recently shown to be critically required for preventing B16 lung metastases (28) . We therefore analyzed distinct lung myeloid cell populations and found high TIM-4 expression on CD11b
−
CD11c
hi DCs from wild-type mice but not on those from Vps34 f/f ;CD11c-Cre mice (Fig. S10A) . These results suggest that the TIM-4-expressing CD11b
−
CD11c
hi population of DCs in the lungs plays a role in controlling tumor metastasis.
We considered the possibility that the increased tumor burden in Vps34 f/f ;CD11c-Cre mice may be related to spontaneous cytokine production by DCs in these animals. We therefore evaluated CD11b
+
Gr1
+ myeloid-derived suppressor cells, which promote tumor growth and are induced in response to inflammatory stimuli (29) , but found no difference in the frequency of these cells in mutant and wild-type animals (Fig. S10B ).
Discussion
The class III PI3K Vps34 plays a role in endocytosis, intracellular vesicular trafficking, and autophagy, key processes that control the presentation of self and foreign antigens by DCs to naive T lymphocytes. Here we analyzed DC functions in mice with a DCspecific Vps34 gene ablation. DCs from these animals exhibited a decrease in the ratio of CD8α + to CD8α − subsets that was cell intrinsic and mediated by impaired DC homeostasis. Although the frequency of CD8α + DCs was reduced in Vps34 f/f ;CD11c-Cre mice, these cells retained their capacity to cross-present the model antigen OVA to MHC class I-restricted T cells when delivered in a soluble form through the DEC205 receptor and via expression in bacteria but were profoundly impaired in their capacity to cross-present OVA antigens associated with dying cells. This impaired capacity was associated with reduced expression of TIM-4, a receptor predominantly expressed by CD8α + DCs that binds with phosphatidylserine to engulf apoptotic cells (22, 27) . Therefore, the combined defect in the homeostatic maintenance of CD8α + DCs and blunted efferocytosis in Vps34 f/f ;CD11c-Cre mice resulted in impaired induction of CTL responses to antigens associated with dying cells and defective antimetastatic immunity. Although our findings suggest defective TIM-4 expression as a likely cause for the impaired efferocytosis by Vps34-deficient DCs, additional phagocytic receptors for apoptotic cells may be involved. In addition to autophagy, Vps34 plays a role in endocytosis (9, 30) . Our findings showed that DCs from Vps34 f/f ;CD11c-Cre mice lack significant defects in endocytosis or phagocytosis but exhibit abnormalities in autophagosomal double-membrane structures and mitochondrial ER mass, suggesting defective autophagy as the main process responsible for the observed alterations in DC functions.
Vps34 has been implicated in both canonical and noncanonical autophagy (31) . During the induction of canonical autophagy the preinitiation complex triggers recruitment of the Beclin1-Vps34 complex, followed by induction of Vps34 kinase activity, recruitment of multiple Atg proteins, and lipidation of LC3. This process allows the formation of double-membrane autophagosomal structures, which ultimately fuse with lysosomes to degrade the contents of the autophagosomes (9) . In our previous studies we demonstrated that deletion of Vps34 in T cells, heart, or liver results in profound defects in canonical autophagy and in the loss of normal cellular function in vivo (11, 13) . Vps34 deficiency in DCs similarly caused defects in canonical autophagy, resulting in the complete loss of visible double-membrane autophagosomal structures, the accumulation of cellular organelles, and increases in ER and mitochondrial mass. In the noncanonical autophagy pathway, TLR activation induces the recruitment of several Atg proteins such as LC3 to a single-membrane phagosome. Such LC3-enriched phagosomes degrade their contents more efficiently and thus modulate immune responses triggered by the engulfed cargo (32) . This process of noncanonical autophagy, also known as "LAP," requires the activity of the Beclin1-Vps34 complex before recruitment of LC3 to phagosomes (33, 34) . A recent study has demonstrated that the Vps34 complex is critically required for the induction of LAP and for canonical autophagy in macrophages (26) . Therefore the spontaneous activation and cytokine secretion by Vps34-deficient DCs may be potentially attributed to deficiencies in the anti-inflammatory activity of canonical autophagy, to LAP, or to both. Our results with mice deficient in Rubicon, which binds Vps34 and is required for LAP but not for canonical autophagy (26) , suggest that defects in Vps34-deficient DCs are not caused by defective LAP. Although these findings are consistent with defective canonical autophagy being the cause of the observed phenotype of Vps34-deficient DCs, defects in additional cellular processes that involve Vps34 may contribute as well.
Autophagy has been shown to play a role in processing antigens for presentation to MHC class I-and class II-restricted T cells (4) . Surprisingly, we found enhanced antigen presentation via the conventional MHC class I and class II pathways by Vps34-deficient DCs. Our electron microscopic analyses of Vps34-deficient DCs revealed increased accumulation of ER membranes. Such an expanded ER compartment, rich in the components of the MHC class I processing machinery, may allow efficient processing of cytosolic proteins for presentation onto MHC class I-restricted T cells. Thus, a combination of factors, including increased sensitivity of partially activated Vps34-deficient DCs to IFN-γ stimulation, together with defects in autophagy resulting in an expansion of the MHC class I peptide-loading compartment, may contribute to the observed enhancement in MHC class I-restricted antigen presentation. In professional APCs such as DCs, MHC class II-presented antigens reach phagosomes via endocytosis or pinocytosis. These phagosomes then fuse with MHC class II-containing endosomal compartments in which the antigens are degraded and peptides are loaded onto MHC class II-restricted T cells (35) . Although our results showed enhanced MHC class II-restricted antigen presentation by Vps34-deficient DCs, we found a modest defect rather than enhancement in the uptake of antigens by Vps34-deficient DCs. A recent study provided evidence that autophagosomal vesicles constantly fuse with the MHC class II peptide-loading compartment and facilitate antigen presentation (36) . The increased accumulation of electron-dense lysosomal structures observed in Vps34-deficient DCs might explain the enhanced MHC class II-restricted antigen presentation.
Targeting Vps34 to inhibit autophagy has recently been considered as an anticancer therapy (37) . Autophagy protects cancer cells against metabolic stress such as nutrient starvation and hypoxic conditions. Inhibiting autophagy in cancer cells therefore may reduce resistance to chemotherapy and radiation therapy. A selective Vps34 inhibitor, SAR405, in combination with the mammalian target of rapamycin (mTOR) inhibitor everolimus, was shown to inhibit the proliferation of renal tumor cell lines in vitro (38) . Our results suggest that Vps34 inhibition may lead to impaired T-cell-mediated immunity in tumors that may limit the utility of SAR405 in cancer therapy.
Materials and Methods
Reagents, electron microscopy, analyses of mitochondrial and ER stress, Western blotting, lung cell preparation, DC activation experiments, antigenpresentation assays, endocytosis and phagocytosis assays, quantitative realtime PCR, TIM-4 overexpression, and induction of lung metastases are described in SI Materials and Methods.
Mice. Vps34
f/f (11, 13) , Rubicon −/− (26), and TAP −/− (39) mice have been described. CD11c-Cre, OT-I, and OT-II transgenic mice were obtained from The Jackson Laboratory. All mice were housed under specific pathogen-free conditions and in compliance with guidelines from the Institutional Animal Care and Use Committee at Vanderbilt University. Isolation of Splenic DCs and Generation of BMDCs. Spleens were treated with 0.2 mg/mL of collagenase D and DNase I for 15-20 min in plain Roswell Park Memorial Institute (RPMI) medium at 37°C. DCs were purified based on the expression of CD11c and MHC class II using FACS as described previously (40) , at a final purity greater than 75%. CD8α microbeads (Miltenyi Biotec) were used to sort CD8α + DCs, and the remaining cells were used as CD8α − DCs. BMDCs were generated using recombinant GM-CSF as described (41, 42) . For Flt3L-driven BMDCs, 1.5 × 10 6 bone marrow cells/mL were cultured in 4 mL of complete medium for 9 d in the presence of 150 ng/mL of recombinant FMS-like tyrosine kinase-3 ligand (rFlt3L) as described (43) .
In Vitro and in Vivo Phagocytosis of Cell Corpses. In vitro and in vivo dead cell uptake assays were performed as described (44) Statistical Analyses. Statistical significance was determined by an unpaired two-tailed Student t test or one-way ANOVA using GraphPad Prism software; P < 0.05 was considered significant. Fig. S1 . Vps34 f/f ;CD11c-Cre mice lack Vps34 expression in DCs but not in macrophages or B cells. DCs, macrophages, and B cells from the spleens of Vps34 f/f or Vps34 f/f ;CD11c-Cre mice were enriched by magnetic sorting. Proteins were prepared, and immunoblot analysis was performed using antibodies against Vps34 and β-actin. Representative data from two independent experiments are shown. Data are pooled from two individual experiments with five mice in each experimental group. *P < 0.01. f/f and Vps34 f/f ;CD11c-Cre mice were purified and stained with anti-CD11c antibodies and MitoTracker red or ER-Tracker green dye according to the manufacturer's protocol. The mitochondrial and ER staining were measured by flow cytometry. An experiment representative of two independent experiments with six mice in each group is shown. *P < 0.01. 
